Dave Gardner joined Incyte in 2025 as Executive Vice President and Chief Strategy Officer. In his role, Dave will serve as a key member of the Executive Leadership Team and be responsible for the Company’s strategy and business development.

With more than 20 years of experience in biopharmaceutical investing and advising, Dave most recently served as a Partner at Rock Springs Capital Management, leading strategy across Oncology, Neurology, Immunology and Rare Diseases. Prior to that, he spent a decade at BlackRock as Vice President and Equity Research Analyst where he was responsible for investments across the Health Care sector.

Dave holds an MBA from Columbia Business School and a bachelor’s degree from the University of Virginia’s McIntire School of Commerce.